Kopeć M, Bykowska K, Lopaciuk S, Jelenska M, Kaczanowska J, Sopata I, Wojtecka E
Thromb Haemost. 1980 Jul 15;43(3):211-7.
Human factor VIII was purified from cryoprecipitate and incubated for up to 24 hours with four neutral proteases of human blood leukocytes, namely, with elastase-like protease (ELP), chymotrypsin-like protease (CLP), collagenase and gelatinase. Electrophoretic patterns showed a reproducible sequence of degradation of factor VIII and of its 230,000 molecular weight subunit by ELP and CLP. Intermediate products were similar but those resulting from exhaustive proteolysis by ELP and CLP differed distinctly from each other. Procoagulant activity of factor VIII was rapidly and completely destroyed by ELP and CLP before visible electrophoretic changes would be detected. No increase in this activity was observed prior to its destruction. Von Willebrand factor (ristocetin cofactor) activity was considerably more resistant to ELP and CLP and declined in rough relation to degradation of highly aggregated forms of factor VIII. ELP and CLP produced a pronounced progressive increase in the Laurell reaction antigen. Normal human plasma showed a high potency to inhibit ELP and CLP. Large doses of these enzymes (300 microgram per ml) produced in the plasma medium only a moderate fall in factor VIII procoagulant activity. Collagenase and gelatinase did neither degrade factor VIII nor change its biological properties.
从冷沉淀中纯化人凝血因子VIII,并将其与四种人血白细胞中性蛋白酶,即弹性蛋白酶样蛋白酶(ELP)、胰凝乳蛋白酶样蛋白酶(CLP)、胶原酶和明胶酶一起孵育长达24小时。电泳图谱显示ELP和CLP对因子VIII及其230,000分子量亚基的降解具有可重复的序列。中间产物相似,但ELP和CLP彻底蛋白水解产生的产物彼此明显不同。在检测到可见的电泳变化之前,ELP和CLP迅速且完全地破坏了因子VIII的促凝活性。在其被破坏之前未观察到该活性增加。血管性血友病因子(瑞斯托菌素辅因子)活性对ELP和CLP的抵抗力要强得多,并且与高度聚集形式的因子VIII的降解大致呈负相关下降。ELP和CLP使劳雷尔反应抗原显著且逐渐增加。正常人血浆对ELP和CLP具有高效抑制作用。在血浆培养基中加入大剂量的这些酶(每毫升300微克)只会使因子VIII促凝活性适度下降。胶原酶和明胶酶既不降解因子VIII,也不改变其生物学特性。